Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large b-cell non-hodgkin lymphoma: A phase ii multicenter study of the fondazione italiana linfomi

S. Storti, M. Spina, E.A. Pesce, F. Salvi, M. Merli, A. Ruffini, G. Cabras, A. Chiappella, E. Angelucci, A. Fabbri, A.M. Liberati, M. Tani, G. Musuraca, A. Molinari, M.P. Petrilli, C. Palladino, R. Ciancia, A. Ferrario, C. Gasbarrino, F. MonacoV. Fraticelli, A. De Vellis, F. Merli, S. Luminari

Research output: Contribution to journalArticlepeer-review

Cite this